Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Seagen
Seagen
Daiichi Sankyo will remain 'dominant' in ADC market for oncology treatments
Biopharma Reporter
Mon, 08/7/23 - 10:14 am
Daiichi Sankyo
antibody drug conjugate
oncology
Seagen
Roche
Seagen, Merck put $1.6B ADC collab on the back burner citing 'emerging treatment landscape'
Fierce Biotech
Thu, 08/3/23 - 06:27 pm
Seagen
Merck
antibody-drug conjugate
Pfizer shuffles R&D leadership to prepare for Seagen merger
Fierce Biotech
Thu, 07/27/23 - 11:44 am
Pfizer
R&D
M&A
Seagen
FTC seeks additional info on Pfizer's proposed takeover of Seagen
Reuters
Sun, 07/16/23 - 02:52 pm
FTC
Pfizer
Seagen
M&A
Biopharma buyouts bounce back
EP Vantage
Wed, 07/5/23 - 10:17 am
M&A
Amgen
Astellas
Eli Lilly
GSK
Horizon Therapeutics
Merck
Novartis
Pfizer
Seagen
Biopharma Companies with the Biggest CEO-Employee Pay Gaps
BioSpace
Thu, 06/15/23 - 09:58 am
Pharma CEOs
executive compensation
Sarepta Therapeutics
Pfizer
Bausch + Lomb
Amneal Pharmaceuticals
Thermo Fisher
IQVIA
McKesson
Royalty Pharma
Charles Rivers Laboratories
Seagen
Pfizer refiles Seagen deal paperwork with regulators
BioPharma Dive
Wed, 06/14/23 - 06:52 pm
Pfizer
Seagen
FTC
M&A
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Novartis
Chinook Therapeutics
Paratek
Sobi
CTI BioPharma
Astellas
Iveric Bio
Assertio Holdings
Spectrum Pharmaceuticals
Merck
Prometheus Biosciences
Pfizer
Seagen
Sanofi
Provention Bio
Sun Pharma
Concert Pharmaceuticals
BioNTech
InstaDeep
AstraXeneca
CinCor Pharma
Ipsen
Albireo
Chiesi
Amryt
Moderna Therapeutics
OriCiro Genomics
Seagen Touts Adcetris Early-Stage Lymphoma Data with 93% Complete Remission
BioSpace
Tue, 06/13/23 - 11:29 am
Seagen
Adcetris
Hodgkin's lymphoma
clinical trials
Medicare sets next tranche of drugs to face price hike penalties
BioPharma Dive
Sun, 06/11/23 - 11:02 pm
Medicare
Inflation Reduction Act
drug pricing
Amgen
Sanofi
Seagen
'I don't have a checklist:' Seagen CEO talks about his next stop, Pfizer deal and the ADC landscape
Fierce Pharma
Thu, 06/8/23 - 09:34 pm
Seagen
Pharma CEOs
David Epstein
Pfizer
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
Wed, 05/24/23 - 11:18 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
Motley Fool
Mon, 05/22/23 - 11:40 am
Pfizer
debt
Seagen
M&A
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
Wed, 05/17/23 - 11:29 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Fierce Pharma
Mon, 05/15/23 - 11:19 am
Pfizer
Seagen
M&A
antitrust
DOJ
FTC
Biopharma Bets Big on Antibody-Drug Conjugates
BioSpace
Mon, 05/8/23 - 10:20 am
antibody-drug conjugate
Merck
Seagen
M&A
AstraZeneca
BioNTech
Bristol Myers Squibb
In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off
Fierce Pharma
Mon, 04/17/23 - 10:49 pm
Pfizer
Seagen
M&A
Merck
Pfizer's fortunes overshadow first-quarter dealmaking
EP Vantage
Wed, 04/12/23 - 10:22 am
M&A
Pfizer
Seagen
Sanofi
Provention Bio
AstraZeneca
CinCor
Chiesi
Amryt
Ipsen
Albireo
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Fierce Pharma
Tue, 04/11/23 - 11:46 am
M&A
antitrust
FTC
Sanofi
Provention Bio
Pfizer
Seagen
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »